ZMUni Compliance Centre

  From May 13 to 22, 2026, 7 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA).      Plant & Biotech   Notification 20260084 - Saussurea Involucrata Callus Extract This NCI was notified by a subsidiary of Veminsyn Biotech (Zhejiang), with compliance support provided by ZMUni Compliance Center. ZMUni previously assisted Veminsyn Biotech in successfully notifying another NCI, Epiphyllum oxypetalum Callus Extract, continuing to safeguard the compliant commercialization of the company's innovations.   The primary active components of Saussurea involucrata are flavonoids and polysaccharides, alongside alkaloids, organic acids, ceramides, volatile oils, trace elements, and

Following China's 2026 "315 Gala" - the country's annual consumer rights program known for exposing market misconduct - the once-booming exosome trend in cosmetics and medical aesthetics has rapidly cooled in China.   But the real story is not the decline of a technology. It is the correction of a market driven by aggressive commercialization, exaggerated claims, and increasingly blurred compliance boundaries.   As the industry moves beyond the hype cycle, exosomes in China are entering a new phase - one shaped less by marketing narratives and more by scientific validation, regulatory expectations, and long-term viability.   What Regulators Are Targeting Is the Misuse of

Toothpaste is one of the most universal consumer healthcare products—but also one of the most inconsistently regulated across global markets.   Depending on the jurisdiction, it may be treated as a cosmetic, an OTC drug, or a hybrid category subject to both cosmetic and pharmaceutical controls. These differences go far beyond terminology: they directly shape product formulation strategy, claims design, regulatory timelines, and market entry feasibility.   For international brands, toothpaste compliance is rarely about meeting a single global standard. Instead, it requires navigating distinct regulatory philosophies in different markets.      China: Notification-Based Cosmetic System   In China, toothpaste is defined

China remains a highly regulated but attractive market for global food exporters. Recent data released by China Customs on rejected food imports in 2025 highlights a number of recurring compliance issues, particularly around labeling, ingredient use, and regulatory alignment.   Against this backdrop, several key compliance considerations have emerged for companies seeking to access the Chinese market.     1. Market access and regulatory entry requirements   Market access remains a foundational step for food imports into China. Overseas manufacturers, exporters, and agents are required to complete registration with the General Administration of Customs of China (GACC).   In addition,

Imports of cosmetics in China reached $16.18 billion, marking a mild 0.9% year-on-year decline—the smallest drop since imports entered a negative growth cycle in 2022 and a significant improvement from the 9.0% contraction in 2024.   Import Slump Eases Significantly, Domestic Market Warms Up   China's cosmetics imports have been in a sustained negative growth phase since 2022, with declines of 10.6%, 19.4% and 9.0% in 2022, 2023 and 2024, respectively, resulting in a total reduction of $8.55 billion over the three years. Although still in negative territory, the marginal 0.9% decline in 2025 signals a clear stabilization and recovery

As global regulatory frameworks for cosmetics and food continue to evolve, companies are facing increasingly detailed requirements around ingredient safety, scientific assessment, and market access. Keeping pace with these changes has become an essential part of everyday regulatory and compliance work.   Throughout 2025, ZMUni Compliance Centre has closely tracked regulatory developments across China and major international markets, while continuing to support clients through practical compliance consulting and project-based regulatory services. Alongside this work, we have also continued to share regulatory updates and practical insights through our website, industry events, and professional communication channels.   Based on this ongoing monitoring and

Innovation in food ingredients continues to drive growth in the global food industry. This article provides a comprehensive overview of China's new food ingredient landscape in 2025. Based on multi-dimensional data analysis, it aims to help global companies strategize for the Chinese food ingredient market in 2026.   I. Overview of New Food Ingredient Applications in China (2025)  As of December 31, 2025, China's National Health Commission (NHC) accepted 53 applications for new food ingredients, marking a record high in recent years. This growth reflects both supportive regulatory policies and sustained innovation efforts by industry players.      Applications by Origin Of the

Nicotinamide mononucleotide (NMN) has long attracted global attention as a promising ingredient in health supplements and functional foods, due to its potential role in supporting cellular metabolism, healthy aging, and overall well-being.   In recent weeks, key regulatory developments driving in major markets have brought clarity to NMN's legal status, creating new opportunities for the supplement industry.      United States: FDA Restores NMN's Dietary Supplement Status   On December 9, 2025, the U.S. Food and Drug Administration (FDA) published a response letter on Regulations.gov, addressing submissions by Chinese company SyncoZymes (Shanghai) Co., Ltd. regarding β-nicotinamide mononucleotide (NMN).    *Image source: Regulations.gov   The